Sarepta Therapeutics, Inc. Equity-NMS: SRPT

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$136.56

52W high :

$159.84

1Y :

72.69%

5Y :

86.41%

EPS(TTM): :

-8.03

Shares O/S :

87.98 M

Market cap :

11.97 B

What is the share price of Sarepta Therapeutics, Inc. today?

Sarepta Therapeutics, Inc. (SRPT) share price as of March 31, 2023, is $136.03. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Sarepta Therapeutics, Inc.?

Yes, Indian Investors can invest in the Sarepta Therapeutics, Inc. (SRPT) Share by opening an international trading account with Angel One.

How can I purchase Sarepta Therapeutics, Inc. shares in India?

Purchasing Sarepta Therapeutics, Inc. (SRPT) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Sarepta Therapeutics, Inc. (SRPT) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Sarepta Therapeutics, Inc.?

Yes, you can purchase fractional shares of Sarepta Therapeutics, Inc. (SRPT) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Sarepta Therapeutics, Inc.?

The market capitalization of Sarepta Therapeutics, Inc. on March 31, 2023, is $11.97 B.

In which sector Sarepta Therapeutics, Inc. belongs?

Sarepta Therapeutics, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Sarepta Therapeutics, Inc. stocks?

In order to invest in Sarepta Therapeutics, Inc. (SRPT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It is developing therapeutic candidates for a range of diseases and disorders, including Duchenne muscular dystrophy (Duchenne), Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) disorders. It commercializes three products, such as EXONDYS 51 (eteplirsen) Injection, VYONDYS 53 (golodirsen) Injection and AMONDYS 45 (casimersen) Injection. These commercial products are indicated for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51, exon 53 and exon 45 skipping. Its pipeline includes more than 40 programs at various stages of discovery, pre-clinical and clinical development.